Tempest Therapeutics (TPST) Return on Invested Capital (2018 - 2025)
Tempest Therapeutics (TPST) posted Return on Invested Capital of 0.02% for Q3 2025, down 32.62% sequentially from 0.02% in Q2 2025, and down 1.0% YoY from 0.02% in Q3 2024.
Tempest Therapeutics (TPST) Return on Invested Capital (2018 - 2025) Analysis & Trends
Tempest Therapeutics has reported Return on Invested Capital for 5 years, with the latest figure at 0.02% in Q3 2025.
- Quarterly Return on Invested Capital fell 1.0% year-over-year to 0.02% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.02% (down 1.0% YoY) and the FY2024 annual result came in at 0.08%, changed N/A from the prior year.
- Return on Invested Capital retreated to 0.02% in Q3 2025 per TPST's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.01% in Q3 2024 and troughed at 0.66% in Q4 2021.
- A 4-year average of 0.09% and a median of 0.02% in 2024 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Return on Invested Capital rose 1 bps in 2024, then decreased 1 bps in 2025.
- Over 4 years, Return on Invested Capital stood at 0.66% in 2021, then surged by 96 bps to 0.03% in 2023, then surged by 45 bps to 0.01% in 2024, then plunged by 69 bps to 0.02% in 2025.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.02%, 0.02%, and 0.02% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.03% |
| Dec 31, 2021 | -0.66% |
| Sep 30, 2018 | -3.43% |
| Jun 30, 2018 | -3.52% |
| Mar 31, 2018 | -4.27% |